Page last updated: 2024-11-06

thymidine and Leishmaniasis, Cutaneous

thymidine has been researched along with Leishmaniasis, Cutaneous in 1 studies

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research Excerpts

ExcerptRelevanceReference
" Thus, Leishmania bearing auxotrophic gene knockouts can be safe and induce protective immunity."1.29Development of a safe live Leishmania vaccine line by gene replacement. ( Beverley, SM; de Freitas, LA; Gueiros-Filho, FJ; Titus, RG, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Titus, RG1
Gueiros-Filho, FJ1
de Freitas, LA1
Beverley, SM1

Other Studies

1 other study available for thymidine and Leishmaniasis, Cutaneous

ArticleYear
Development of a safe live Leishmania vaccine line by gene replacement.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Oct-24, Volume: 92, Issue:22

    Topics: Animals; Gene Targeting; Humans; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Mice; Mice

1995